Skip to main content
SGHT logo

Sight Sciences, Inc.

SGHTNASDAQHealthcareMedical Devices

$8.99Today:- (-)1Y +74.47%

As of Oct 23, 2026 close

Market cap
$490.01M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.38$9.71
Volume (live)
-
Avg. volume (3M)
313.32K

Sight Sciences (SGHT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Sight Sciences reported total assets of $115.30M and total liabilities of $51.36M. Shareholders' equity was $63.94M, down 26.9% from $87.52M a year earlier. Total debt stood at $40.77M against $91.97M in cash and short-term investments, a net cash position of $51.19M. That puts debt-to-equity at 0.64, compared with 0.46 a year earlier.

Sight Sciences Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Sight Sciences, Inc. (SGHT) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents91.97120.36138.13185.00260.6961.5121.244.24
Cash & Short-Term Investments91.97120.36138.13185.00260.6961.5121.244.24
Accounts Receivable9.7510.7914.2915.158.715.364.091.82
Inventory7.776.337.856.113.482.602.240.49
Other Current Assets3.262.312.603.424.161.160.430.62
Total Current Assets112.73139.77162.87209.68277.0470.6328.007.16
Non-Current Assets
Property, Plant & Equipment (Net)2.052.523.103.192.951.792.570.87
Other Non-Current Assets0.520.550.680.210.200.390.170.06
Total Non-Current Assets2.573.073.783.403.152.172.740.93
Total Assets115.30142.84166.65213.07280.1972.8130.748.09
Current Liabilities
Accounts Payable1.341.691.732.693.352.162.321.88
Short-Term Debt0.481.072.221.030.510.400.560.00
Current Portion of Long-Term Debt--2.22-----
Accrued Liabilities9.6813.788.3015.1310.156.76--
Other Current Liabilities9.2112.717.730.009.646.764.461.02
Total Current Liabilities11.0315.4712.2517.8213.509.317.342.90
Non-Current Liabilities
Long-Term Debt40.3039.3631.7133.3132.6631.9613.3834.15
Other Non-Current Liabilities0.030.492.481.871.920.8164.710.01
Total Non-Current Liabilities40.3339.8534.1835.1834.58152.3478.0934.16
Total Liabilities51.3655.3246.4453.0048.0842.2185.4237.06
Stockholders' Equity
Common Stock0.050.050.050.050.050.010.010.01
Retained Earnings-384.72-346.30-294.79-239.24-153.00-90.04-55.35-29.48
Accumulated Other Comprehensive Income0.000.000.000.000.000.00-64.49-34.15
Additional Paid-in Capital448.61433.77414.96399.27385.061.180.6634.67
Shares Outstanding53.4950.9449.1348.3047.50---
Total Stockholders' Equity63.9487.52120.22160.08232.1130.59-54.68-28.96
Total Liabilities & Equity115.30142.84166.65213.07280.1972.8130.748.09

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Sight Sciences Balance Sheet

How much debt does Sight Sciences have?

Sight Sciences had total debt of $40.77M as of Dec 31, 2025, against $91.97M in cash and short-term investments. Its debt-to-equity ratio was 0.64. Total debt was $40.42M a year earlier.

What are Sight Sciences's total assets?

Sight Sciences reported total assets of $115.30M as of Dec 31, 2025, down 19.3% from $142.84M a year earlier. Total liabilities were $51.36M.

What is Sight Sciences's shareholders' equity?

Sight Sciences's shareholders' equity was $63.94M as of Dec 31, 2025, or about $1.20 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition